Extendicare (TSE:EXE) Stock Price Passes Above Two Hundred Day Moving Average – Here’s What Happened

Extendicare Inc. (TSE:EXEGet Free Report)’s stock price crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of C$8.87 and traded as high as C$10.31. Extendicare shares last traded at C$10.27, with a volume of 64,465 shares traded.

Wall Street Analyst Weigh In

A number of research analysts have issued reports on EXE shares. TD Securities upped their target price on shares of Extendicare from C$9.50 to C$10.50 and gave the company a “hold” rating in a research report on Thursday, November 14th. Royal Bank of Canada raised their price objective on shares of Extendicare from C$9.50 to C$11.00 and gave the company a “sector perform” rating in a research note on Thursday, November 28th.

Check Out Our Latest Stock Analysis on Extendicare

Extendicare Stock Down 0.1 %

The company has a debt-to-equity ratio of 305.80, a current ratio of 0.60 and a quick ratio of 0.98. The stock has a market cap of C$857.24 million, a price-to-earnings ratio of 15.10 and a beta of 1.26. The firm has a 50 day simple moving average of C$10.11 and a two-hundred day simple moving average of C$8.87.

Extendicare Dividend Announcement

The company also recently declared a monthly dividend, which was paid on Friday, November 15th. Investors of record on Thursday, October 31st were given a $0.04 dividend. The ex-dividend date was Thursday, October 31st. This represents a $0.48 dividend on an annualized basis and a dividend yield of 4.67%. Extendicare’s dividend payout ratio is 70.59%.

About Extendicare

(Get Free Report)

Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC”) homes and one of the largest private-sector providers of publicly funded home health care services.

Featured Stories

Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.